-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

623.O1.6 623. Mantle Cell, Follicular, Waldenstrom’s, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological: Therapies for Mantle Cell Lymphoma

Symposia: Mantle Cell, Follicular, Waldenstrom’s, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Combination therapy, Research, Adult, Clinical trials, Lymphomas, Non-Hodgkin lymphoma, B Cell lymphoma, Clinical Research, Chemotherapy, Diseases, Indolent lymphoma, Therapy sequence, Treatment Considerations, Real-world evidence, Aggressive lymphoma, Lymphoid Malignancies, Non-Biological therapies, Study Population, Human, Measurable Residual Disease
Saturday, December 7, 2024: 2:00 PM-3:30 PM
Marriott Grand Ballroom 11-13 (Marriott Marquis San Diego Marina)
Moderators:
Preetesh Jain, MD, MBBS, PhD, DM, and Eva Gine, MD, Hospital Clinic of Barcelona. IDIBAPS. University of Barcelona
Disclosures:
Gine: Janssen: Honoraria, Research Funding; Lilly: Honoraria, Research Funding; Roche: Honoraria; Gilead/Kite: Honoraria; Astra-Zeneca: Honoraria.
The oral session 1 focus on Mantle cell lymphoma (as 6 of the top abstracts were of MCL). It contains 4 clinical trials (first 4 abstracts) and 2 studies reporting the outcome of patients after CART progression or relapse.
2:00 PM

David John Lewis, MD1*, Mats Jerkeman, MD, PhD2, Lexy Sorrell3*, David Wright4*, Ingrid Glimelius, MD, PhD5, Annika Pasanen, MD, PhD6*, Jacob Haaber Christensen, MD, PhD7*, Karin Fahl Wader, MD, PhD8*, Andrew J. Davies, MD, PhD9*, Nick Morley10*, Christopher McNamara, MD11*, Christian Bjørn Poulsen, MD, PhD12*, Jon Riise, MD, PhD13*, Kristina Sonnevi, MD PhD14*, Ingemar Lagerlöf, PhD15*, Cathy Burton16*, Surita Dalal, PhD17*, Andrew Rawstron, PhD18*, Ruth M de Tute, MSc, PhD, FRCPath17*, Victoria Allgar19*, Sree Aroori19*, Mark Warner19*, Brian Wainman19*, Claire Scully19*, Jeanette Sanders19*, Carsten Utoft Niemann, MD, PhD20*, Helle Toldbod, PhD, MS21*, Nicola Crosbie1*, Mark J Bishton, PhD, MBChB22, Toby A. Eyre23* and Simon Rule, MD1,24*

1University Hospitals Plymouth NHS Trust, Plymouth, United Kingdom
2Lund University Hospital, Lund, Sweden
3Plymouth University, Faculty of Health, Plymouth, United Kingdom
4Insititute of Health Research, Exeter University, Exeter, United Kingdom
5Department of Immunology, Genetics and Pathology, Cancer Precision Medicine Unit, Uppsala University, Uppsala, Sweden., Uppsala University, Uppsala, Sweden
6Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
7Dept. of Hematology, Odense University Hospital, Odense, Denmark
8St Olav University Hospital, Department of Oncology, Trondheim, Norway
9Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, United Kingdom
10Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom
11University College London Hospitals NHS Foundation Trust, London, United Kingdom
12Department of Hematology, Zealand University Hospital, Roskilde, Denmark
13Department of Oncology, Oslo University Hospital, Oslo, NOR
14Karolinska University Hospital, Department of Haematology, Stockholm, Sweden
15Linkoping University Hospital, Linkoping, Sweden
16Haematology, Leeds Cancer Centre, Leeds, United Kingdom
17HMDS, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
18Haematological Malignancy Diagnostic Service, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
19Plymouth University, Peninsula Clinical Trials Unit, Plymouth, United Kingdom
20Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark
21Aarhus University Hospital, Aarhus C, DNK
22Nottingham University Hospitals NHS Trust, Nottingham, UK, United Kingdom
23Department of Clinical Haematology, Oxford University Hospitals NHS Trust, Old Road, United Kingdom
24Executive Director, Haematology R&D, AstraZeneca, Cambridge, United Kingdom

2:15 PM

Nina D. Wagner-Johnston, MD1, Opeyemi Jegede2*, Stephen E Spurgeon, MD3, Kami J. Maddocks, MD4, David T Yang, MD5, Justin Romanoff6*, Jonas Paludo, MD7, Paolo F. Caimi, MD8, Nancy L. Bartlett, MD9*, Patrick M. Reagan, MD10, Yazeed Sawalha, MD11, Marc Hoffmann, MD12, Boyu Hu, MD13, Ashraf R Aziz14*, Helga Marques6*, Lale Kosakoglu Shields15*, John P. Leonard, MD16, Jonathan W. Friedberg, MD17 and Brad S. Kahl, MD18

1Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD
2Dana Farber Cancer Institute, Boston, MA
3Knight Cancer Institute, Oregon Health & Science University, Portland, OR
4The James Cancer Center, The Ohio State University, Columbus, OH
5Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI
6Brown University, Providence
7Division of Hematology, Mayo Clinic, Rochester, MN
8Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
9Washington University School of Medicine, St. Louis, MO
10University of Rochester School, Fairport, NY
11Division of Hematology, The Ohio State University, Columbus, OH
12University of Kansas Cancer Center, Kansas City, KS
13Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
14Kaiser Permanente, Anaheim
15NYU Langone, New York
16Weill Cornell Medicine, New York, NY
17Wilmot Cancer Center, University of Rochester, Rochester, NY
18Washington University School of Medicine in St. Louis, St. Louis, MO

2:30 PM

Marco Ladetto1, Katja* Gutmair2*, Jeanette K Doorduijn, MD, PhD3, Eva Gine, MD4, Mats Jerkeman, MD, PhD5, Jan Walewski, MD, Prof.6, Martin Hutchings, MD, PhD7, Ulrich Mey, MD, Prof.8,9, Jon Riise, MD, PhD10*, Marek Trneny, Prof., MD, CSc.11, Vibeke KJ Vergote, MD12*, Piero Maria Stefani, MD13*, Netanel A. Horowitz, MD14,15*, Maria Gomes da Silva, MD, PhD16, Sirpa Leppä, MD, PhD17, Linmiao Jiang, MSc18*, Christiane Pott, MD19*, Wolfram Klapper, MD, Prof20*, Christian Schmidt, MD21*, Michael Unterhalt22*, Martin* Dreyling, MD23 and Eva* Hoster, Prof24,25*

1Department of Translational Medicine, Università del Piemonte Orientale ed SCDU Ematologia AOU SS Antonio e Biagio e Cesare Arrigo, Alessandria, Piedmont, Italy
2Institute of Medical Information, University of Munich, Munich, Germany
3Departement of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
4Department of Hematology, ICAMS, Hospital Clínic de Barcelona, Barcelona, Spain
5Division of Oncology, Department of Clinical Sciences Lund, Skåne University Hospital, Skane University Hospital, Lund, Skaane Laen, Sweden
6Department of Lymphoid Malignancies, Maria Skłodowska-Curie National Research Institute of Oncology, Warszawa, Poland
7Department of Hematology, Rigshospitalet, Copenhagen, Denmark
8Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland
9Oncology and Hematology, Cantonal Hospital Grisons, Chur, GR, Switzerland
10Department of Oncology, Oslo University Hospital, Oslo, NOR
11First Department of Internal Medicine - Hematology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
12Department of Hematology, University Hospitals Leuven, Leuven, Belgium
13Ospedale Ca Foncello - S.C di Ematologia, Treviso, ITA
14Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
15The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technology,, Haifa, Israel
16Inst. Portuges de Oncologia, Lisbon, PRT
17Department of Oncology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
18Institute for Medical Information Processing, Biometry and Epidemiology (IBE), LMU University Munich, Munich, Germany
19Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein, Kiel, Germany
20Department of Pathology, Hematopathology Section, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
21Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
22Department of Internal Medicine III, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany
23Department of Medicine III, University Hospital of the LMU, Munich, Germany
24Department of Internal Medicine III, LMU University Hospital Munich, Munich, Germany
25Institute of Medical Data Processing, Biometrics and Epidemiology (IBE), LMU Munich, Munich, Germany

2:45 PM

Zachary D. Epstein-Peterson, MD1,2, Anath C. Lionel, MD PhD3*, Ashlee Joseph, BS1*, Esther Drill, DrPH4*, Suheil Albert Atallah-Yunes, MD5, Taylor R. Brooks, MD6, Elise A. Chong, MD7,8, Emeline R. Chong8*, Jamie Dela Cruz9*, Matthew J. Frank10,11, Andrew Ip, MD, MSc12, Madiha Iqbal, MD13, Caron A. Jacobson, MD, MMSc14, Manali K. Kamdar, MD15, Reem Karmali, MD16,17, Kami J. Maddocks, MD18, Matthew Matasar, MD, MS19, Reid W. Merryman, MD14, Javier Munoz, MD20*, Peter A. Riedell, MD21, Christine E. Ryan, MD14, Gilles Salles, MD, PhD22,23, Craig S. Sauter, MD24, Yazeed Sawalha, MD25, Roni Shouval, MD, PhD26,27, Navika Shukla, MD28, Alexander V. Stanisic, MD29*, Dylan Therwhanger, MD8*, Herman Van Besien, md30, Yucai Wang, MD, PhD31, Samuel Yamshon, MD32*, Andrew D. Zelenetz, MD, PhD1, Maria Lia Palomba, MD1,23, Preetesh Jain, MD, MBBS, PhD, DM33 and Anita Kumar, MD34

1Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Department of Medicine, Weill Cornell Medical College, New York, NY
3Department of Lymphoma and Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX
4Memorial Sloan Kettering Cancer Center, New York, NY
5Division of hematology, Mayo Clinic, Rochester, MN
6Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
7Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
8Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
9Dana Farber Cancer Institute, Boston, MA
10Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA
11Stanford Cancer Institute, Center for Cancer Cell Therapy, Stanford University School of Medicine, Stanford, CA
12Lymphoma Division, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ
13Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL
14Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
15University of Colorado, Denver, CO
16Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL
17Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
18The James Cancer Center, The Ohio State University, Columbus, OH
19Division of Blood Disorders, Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, New York, NY
20Mayo Clinic, Phoenix, AZ
21Department of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL
22Lymphoma Service Chief, Memorial Sloan Kettering Cancer Center, New York, NY
23Department of Medicine, Weill Cornell Medical College, New York
24Department of Hematology and Medical Oncology Cleveland Clinic, Cleveland, OH
25Division of Hematology, The Ohio State University, Columbus, OH
26Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
27Department of Medicine, Weill Cornell Medicine, New York, NY
28Department of Medicine, University of Chicago, Chicago, IL
29Northwestern University Feinberg School of Medicine, Chicago, IL
30Weill Cornell Medicine, New York, NY
31Division of Hematology, Mayo Clinic, Rochester, MN
32Division of Hematology and Oncology, Weill Cornell Medical College, New York, NY
33Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
34Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ

3:00 PM

Marion Aymard1*, Morgane Cheminant, MD, PhD2*, Roch Houot, MD, PhD3*, Anne Cuozzo4*, Elodie Gat5*, Catherine Thieblemont, MD6, Laure Ricard, MD7*, Louise Roulin, MD8*, Krimo Bouabdallah, MD9*, Violaine Safar, MD10*, Stephanie Guidez11*, Amandine Fayard, MD12*, Gabriel Brisou, MD, PhD13*, Loic Ysebaert, MD, PhD14*, Olivier Hermine, MD, PhD15, Benoit Tessoulin, MD, PhD16*, Charles Herbaux, MD, PhD17*, Steven Le Gouill, MD, PhD18 and Clementine Sarkozy19*

1Department of Hematology, Institut Curie, Saint-Cloud, France
2Hopital Necker - Enfants Malades, AP-HP, Department of Hematology, Paris, France
3Rennes university hospital - Hospital Pontchaillou, Rennes, France
4Department of biostatistics, Lymphoma Academic Research Organisation (LYSARC), Pierre Benite, France
5Department of biostatistics, Lymphoma Academic Research Organisation (LYSARC), Pierre Bénite, France
6Hospital Saint-Louis, Paris, France
7Department of hematology, Saint Antoine Hospital, APHP, Paris, France
8Department of hematology, Henri Mondor Hospital, APHP, Creteil, France
9Bordeaux university hospital, Haut-Leveque, Department of hematology, Bordeaux, France
10Department of hematology, Lyon Sud university hospital, HCL, Lyon, France
11Department of hematology, Poitiers university hospital, Poitiers, France
12Department of hematology, Clermont-Ferrand university hospital, Clermont-Ferrand, France
13Department of Hematology, Institut Paoli-Calmettes, Marseille, France
14Department of hematology, Purpan university hospital, Toulouse, Toulouse, France
15Hematology, Necker Hospital, Greater Paris University Hospitals (AP-HP), Paris, France
16Department of hematology, Nantes university hospital, Nantes, France
17Department of Hematology, Montpellier university hospital, Montpellier, France
18Institut Curie, Saint-Cloud, France
19Department of Hematology, Institut Curie, Saint Cloud, France

3:15 PM

Martin Dreyling, MD1, Jeanette K Doorduijn, MD, PhD2, Eva Gine, MD3, Mats Jerkeman, MD, PhD4, Jan Walewski, MD, Prof.5, Martin Hutchings, MD, PhD6,7, Ulrich Mey, MD, Prof.8,9, Jon Riise, MD, PhD10*, Marek Trneny, Prof., MD, CSc.11, Vibeke KJ Vergote, MD12*, Daniela Donnarumma13*, Ofer Shpilberg, MD, MPH14*, Maria Gomes da Silva, MD, PhD15*, Sirpa Leppä, MD, PhD16, Linmiao Jiang, MSc17*, Christiane Pott, MD18*, Wolfram Klapper, MD, Prof19*, Christian Schmidt, MD20*, Michael Unterhalt, MD21*, Marco Ladetto, MD22 and Eva Hoster, PhD, Prof.23,24*

1Department of Internal Medicine III, LMU University Hospital of Munich, Munich, Germany
2Departement of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands
3Hematology Department, Hospital Clínic of Barcelona, IDIBAPS, CIBERONC, Barcelona, Spain
4Division of Oncology, Lund University, Skåne University Hospital, Lund, Sweden
5Maria Sklodowska-Curie National Research Institute of Oncology, Warszawa, Poland
6Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
7Department of Hematology, Rigshospitalet, Copenhagen, Denmark
8Oncology and Hematology, Kantonsspital Graubünden, Chur, Switzerland
9Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland
10Department of Oncology, Oslo University Hospital, Oslo, NOR
11First Department of Internal Medicine - Hematology, General University Hospital and First Faculty of Medicine, Charles University, Prague, Czech Republic
12Department of Hematology, University Hospitals Leuven, Leuven, Belgium
13Hematology-Oncology & Stem Cell Transplantation Unit, National Cancer Institute Fondazione 'G. Pascale', IRCCS, Naples, Italy
14Institute of Hematology, Assuta Medical Center, Tel-Aviv, Israel
15Departamento de Hematologia, Instituto Português de Oncologia, Lisboa, Portugal
16Department of Oncology, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
17Institute for Medical Information Processing, Biometry and Epidemiology (IBE), LMU University Munich, Munich, Germany
18Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein, Kiel, Germany
19Department of Pathology, Hematopathology Section, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany
20Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
21Department of Internal Medicine III, LMU University Hospital Munich, Munich, DEU
22Department of Translational Medicine, Università del Piemonte Orientale ed SCDU Ematologia AOU SS Antonio e Biagio e Cesare Arrigo, Alessandria, Piedmont, Italy
23Institute of Medical Data Processing, Biometrics and Epidemiology (IBE), LMU Munich, Munich, Germany
24Department of Internal Medicine III, LMU University Hospital Munich, Munich, Germany

*signifies non-member of ASH